Location History:
- Heidelberg, DE (2013)
- Mannheim, DE (2016)
Company Filing History:
1 out of 1 
1 out of 155 
1 out of 1 Years Active: 2013-2016
Title: David Capper: Innovator in Cancer Diagnostics
Introduction
David Capper is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of cancer diagnostics, holding 2 patents that focus on innovative methods for diagnosing various types of cancer. His work is pivotal in advancing diagnostic tests and tools that can improve patient outcomes.
Latest Patents
One of Capper's latest patents is titled "Means and methods for diagnosing cancer using an antibody which specifically binds to BRAF V600E." This invention relates to diagnostic tests and tools, specifically a method for diagnosing cancer in a sample from a subject suspected of having cancer. The method involves contacting the sample with an antibody that binds to a specific epitope on a BRAF polypeptide, allowing for the diagnosis of cancer based on the binding results. Another significant patent is "Methods for the diagnosis and the prognosis of a brain tumor." This invention outlines methods for diagnosing brain tumors and estimating prognosis using the presence or absence of a particular IDH1 mutation as a marker.
Career Highlights
Throughout his career, David Capper has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum (German Cancer Research Center) and Ruprecht-Karls-Universität Heidelberg. His work in these institutions has been instrumental in developing advanced diagnostic methods that are crucial for cancer research and treatment.
Collaborations
Capper has collaborated with notable colleagues, including Andreas Von Deimling and Hanswalter Zentgraf. These partnerships have further enriched his research and contributed to the advancements in cancer diagnostics.
Conclusion
David Capper's innovative work in cancer diagnostics exemplifies the impact of research and invention in the medical field. His patents and collaborations continue to pave the way for improved diagnostic tools that can significantly benefit patients.